Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...

Novo Nordisk said on Friday the U.S. Food and Drug Administration has granted accelerated approval for its weight-loss drug ...

Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...

Novo Nordisk A/S’s weight-loss drug Wegovy has received FDA approval to treat a serious form of liver disease, giving the ...

The shot was cleared for the disease known as MASH, or metabolic-associated steatohepatitis, in adults with moderate to ...

Eli Lilly's obesity drugs delivered 38% revenue growth in the second quarter; but its oral GLP-1 candidate fell short, ...

The medical world relies on horseshoe crab blood in the production of vaccines and equipment. A synthetic is available, but ...

The former This Morning presenter, 63, has long been open about her struggles with her weight, which have seen her fluctuate ...

Fundsmith has invested in some excellent companies, but it has struggled to decide when to sell, says Max King ...

From geopolitics to climate, tech to social change, News18 World live blog delivers real-time updates on what is the latest ...

FREE TO READ] Russian president offered at Alaska summit to freeze front lines if Ukraine withdraws from crucial eastern area ...

An estimated 2·1 billion adults worldwide are affected by overweight and obesity, a figure projected to reach 3·8 billion by ...